Paroma Arefin | Pharmaceutical Science | Women Researcher Award

Published on by Academic Achievements

Women Researcher Award

Paroma Arefin
Affiliation University of Houston
Country United States
Scopus ID 57041256700
Documents 15
Citations 67
h-index 6
Subject Area Pharmacology, Toxicology and Pharmaceutical Science
Event International Academic Achievements & Awards
ORCID 0000-0002-5968-1002

Paroma Arefin

Institution: University of Houston, United States

Paroma Arefin is a researcher whose scholarly work spans pharmaceutical sciences, proton exchange membrane fuel cells, hydrogen energy technologies, biomaterials, and public health research. Her interdisciplinary publications demonstrate contributions to pharmaceutical formulation, sustainable energy systems, healthcare technologies, and consumer health awareness. Through peer-reviewed research, she has participated in studies addressing fuel cell durability, drug delivery systems, mobility assistance technologies, and healthcare education, reflecting an interdisciplinary approach that bridges engineering and pharmaceutical sciences.[1]

Abstract

This article summarizes the academic profile and research achievements of Paroma Arefin in recognition of the Women Researcher Award. Her publications primarily address proton exchange membrane fuel cells, hydrogen-powered transportation, pharmaceutical formulation, biomaterials, and healthcare studies. These contributions demonstrate interdisciplinary scholarship that combines pharmaceutical sciences with emerging sustainable energy technologies and applied healthcare research. Her publication record, citation profile, and collaborative research activities illustrate continued participation in internationally visible scientific literature.[1][2]

Keywords

Women Researcher Award, Paroma Arefin, Pharmaceutical Science, Proton Exchange Membrane Fuel Cell, Hydrogen Energy, Drug Delivery, Biomaterials, Fuel Cell Durability, Healthcare Research, University of Houston.

Introduction

Interdisciplinary scientific research increasingly contributes to addressing global healthcare and energy challenges. Paroma Arefin’s scholarly work reflects this trend through publications involving pharmaceutical formulations, hydrogen fuel cell technology, mobility assistance devices, and public health awareness. Her research integrates engineering concepts with pharmaceutical sciences to explore practical solutions that may contribute to healthcare innovation and sustainable energy development.[2]

Research Profile

  • Affiliation: University of Houston.
  • Research specialization includes Pharmacology, Toxicology and Pharmaceutical Science.
  • Scopus Author ID: 57041256700.
  • Research output includes interdisciplinary studies in pharmaceutical sciences, hydrogen fuel cells and healthcare.
  • Publication metrics include 15 indexed documents, 67 citations and an h-index of 6.

Research Contributions

Paroma Arefin has co-authored review articles examining durability factors affecting proton exchange membrane fuel cells, including the influence of operating temperature and membrane degradation mechanisms. These studies provide comprehensive overviews of hydrogen fuel cell technologies and summarize engineering challenges affecting long-term performance.[3]

Her pharmaceutical research includes formulation and characterization of controlled-release microspheres containing Fexofenadine hydrochloride, contributing to studies on drug delivery systems and controlled pharmaceutical release technologies.[4]

Additional publications address consumer awareness regarding food adulteration, mobility assistive devices for elderly populations, and hydrogen-powered transportation systems, demonstrating broad interdisciplinary engagement across engineering and health sciences.[5]

Publications

  • Effect of temperature on the performance factors and durability of proton exchange membrane of hydrogen fuel cell: A narrative review (2020).
  • Proton exchange membrane fuel cell durability factors, challenges, and future perspectives: A detailed review (2021).
  • Study on awareness about food adulteration and consumer rights among consumers in Dhaka, Bangladesh (2020).
  • Adoption of hydrogen fuel cell vehicles and its prospects for the future: A review (2022).
  • Design, characterization and in vitro evaluation of HPMC K100 M CR loaded Fexofenadine HCl microspheres (2016).
  • A comparison of mobility assistive devices for elderly and patients with lower limb injury: Narrative Review.

Research Impact

Citation indicators demonstrate measurable academic visibility within pharmaceutical science and hydrogen energy research. Review articles concerning proton exchange membrane fuel cells have contributed to knowledge synthesis in sustainable energy technologies, while pharmaceutical formulation studies support advances in controlled drug delivery. Collectively, these works reflect interdisciplinary collaboration and continued scholarly engagement across multiple research domains.[1][3]

Award Suitability

Based on her documented publication record, interdisciplinary collaborations, citation profile, and research contributions spanning pharmaceutical sciences, hydrogen fuel cell technologies, healthcare applications, and public health, Paroma Arefin demonstrates characteristics consistent with recognition through the Women Researcher Award. Her research portfolio illustrates continued scholarly activity, international collaboration, and contributions to scientific literature relevant to sustainable technologies and pharmaceutical innovation.[1]

Conclusion

Paroma Arefin’s academic record demonstrates interdisciplinary scholarship across pharmaceutical science, sustainable energy technologies, healthcare engineering, and biomedical research. Her publications, citation metrics, and collaborative research activities collectively represent meaningful contributions to contemporary scientific literature. The combination of pharmaceutical innovation and engineering-focused sustainability research supports her recognition within international academic award programs.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Paroma Arefin, Author ID 57041256700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57041256700
  2. Salam, M. A., Habib, M. S., Arefin, P., Ahmed, K., Uddin, S., Hossain, T., & Papri, N. (2020).
    Effect of Temperature on the Performance Factors and Durability of Proton Exchange Membrane of Hydrogen Fuel Cell: A Narrative Review.
    Material Science Research India, 17(2), 179–191.
    DOI: https://doi.org/10.13005/msri/170207
  3. Habib, M. S., Arefin, P., Salam, M. A., Ahmed, K., Uddin, M. S., Hossain, T., Papri, N., et al. (2021). Proton Exchange Membrane Fuel Cell (PEMFC) Durability Factors, Challenges, and Future Perspectives: A Detailed Review.
    Material Science Research India, 18(2), 217–234.
    DOI: https://doi.org/10.13005/msri/180209
  4. Arefin, P., Hasan, I., & Reza, M. S. (2016).
    Design, Characterization and In Vitro Evaluation of HPMC K100 M CR Loaded Fexofenadine HCl Microspheres.  SpringerPlus, 5, 691. DOI: https://doi.org/10.1186/s40064-016-2322-2
  5. Habib, M. S., & Arefin, P. (2022).
    Adoption of Hydrogen Fuel Cell Vehicles and Its Prospects for the Future (A Review).
    Oriental Journal of Chemistry, 38(3), 621–631. DOI: https://doi.org/10.13005/ojc/380311

Eni Bushi | Pharmaceutical | Best Review Paper Award-7740

Published on by Academic Achievements

Dr. Eni Bushi | Pharmaceutical | Best Review Paper Award

Dr. Eni Bushi | Pharmaceutical – PhD student at University of Medicine Tirana, Albania

Eni Bushi (Beçi) is a dynamic pharmaceutical professional and researcher whose work bridges academia and the pharmaceutical industry. With extensive experience in pharmaceutical technology, quality assurance, and public health, she has made significant contributions both as a researcher and a leader in pharmaceutical practice. As the current Head of the Quality Assurance Department at Profarma sh.a. and a faculty member at the University of Medicine in Tirana, she plays a crucial role in shaping drug development standards and mentoring emerging professionals. A member of key scientific bodies such as NanoAlb and the Academy of Pharmacy “Eureka,” she exemplifies a strong commitment to advancing pharmaceutical knowledge through rigorous scientific inquiry and industry innovation.

Profile Verified

Scopus

Education

Eni Bushi holds a Master of Science in Pharmaceutical Sciences from the University of Medicine, Tirana, where she graduated with a perfect GPA and defended a thesis focused on prescription practices among elderly patients. Demonstrating her multidisciplinary outlook, she pursued a Master of Business Administration (MBA) at the University of New York Tirana, concentrating on healthcare management, with a thesis on Lean implementation in health systems. Currently, she is a PhD candidate in Pharmaceutical Technology at the same university, focusing on innovative semisolid formulations and their stability. Her academic journey has been enhanced by international certifications and professional development courses in nanotechnology, analytical validation, and Good Laboratory Practices.

Experience

Professionally, Eni Bushi has cultivated a strong career trajectory from community pharmacy to pharmaceutical manufacturing and research. Starting as a community pharmacist, she developed early experience in patient care and medication management. She then transitioned to Profarma sh.a., where she rose from Specialist to Head of the Quality Assurance Department, leading regulatory compliance, validation processes, and interdepartmental coordination. Simultaneously, she has served as a laboratory assistant and research mentor at the University of Medicine in Tirana. Her industry-academic hybrid role enables her to influence both pharmaceutical practice and education, while also fostering research innovation in drug development and regulatory science.

Research Interest

Eni Bushi’s research interests center on pharmaceutical technology, quality systems, antimicrobial resistance, and health systems improvement. Her current doctoral research focuses on semisolid drug formulations, with an emphasis on their physicochemical stability and comparative efficacy. She is particularly interested in integrating nanotechnology into drug delivery systems, and has pursued specialized training in nanomedicine. Her previous studies have explored the knowledge and behavior surrounding antibiotic use, as well as Lean strategies in healthcare environments. These interdisciplinary themes reflect her goal of advancing public health outcomes through innovation in drug formulation and pharmaceutical services.

Awards

Throughout her academic and professional journey, Eni Bushi has received recognition for her academic excellence and leadership. She was awarded the “Excellent Student” distinction by the University of Tirana’s Rectorate and has been consistently invited to contribute to international forums and scientific conferences. Her nomination for the Best Review Paper Award is underpinned by a record of impactful publications, academic mentorship, and a leadership role in pharmaceutical quality assurance.

Selected Publications

  1. 📘 Evaluation of the Knowledge, Attitude and Public Awareness about the Use of Antibiotic and Antibiotic Resistance in Albania (2024) – Indian Journal of Pharmaceutical Education and Research. Cited by 6 articles.
  2. 🧴 Formulation, Preparation and Evaluation of a Natural Cosmetic Product (2023) – Albanian Journal of Medical and Health Sciences. Cited by 3 articles.
  3. 🏥 Using Expert Consensus to Evaluate the Readiness Factors of Lean Implementation in Healthcare (2022) – International Journal of Scientific Research and Management. Cited by 9 articles.
  4. 👵 Prevalence and Factors Associated with Potentially Inappropriate Prescriptions among Older Patients at Hospital Discharge in Albania (2016) – Journal of Evaluation in Clinical Practice. Cited by 28 articles.
  5. 🧪 Theoretical Aspects of the Application of “Quality by Design” Approach in Drug Formulation (2025, Thesis Supervision) – Unpublished.
  6. 💊 Prevalence Assessment and Analysis of Self-Reported Use of Stimulant and Sedative Drugs among University Students (2023, Thesis Supervision) – University of Medicine, Tirana.
  7. 🧬 Analysis on the Level of Knowledge, Attitude, and Public Awareness Towards the Use of Antibiotics and Antimicrobial Resistance (2021, Thesis Supervision) – University of Medicine, Tirana.

Conclusion

Eni Bushi demonstrates a strong and evolving profile as a researcher, practitioner, and academic leader in the field of pharmaceutical sciences. Her combined background in pharmacy, business management, and pharmaceutical technology positions her uniquely to contribute to transformative change in drug formulation, health policy, and quality assurance. Her dedication to innovation, public health, and regulatory science makes her a highly deserving candidate for the Best Review Paper Award. Her work not only exemplifies academic excellence but also provides practical value to both the pharmaceutical industry and healthcare systems in Albania and beyond.